<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31004418</article-id>
<article-id pub-id-type="pmc">6565594</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.658</article-id>
<article-id pub-id-type="publisher-id">MGG3658</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The frequency of <styled-content style="fixed-case">CNV</styled-content>s in a cohort population of consecutive fetuses with congenital anomalies after the termination of pregnancy</article-title>
<alt-title alt-title-type="left-running-head">RUDOLF et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="mgg3658-cr-0001">
<name>
<surname>Rudolf</surname>
<given-names>Gorazd</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3863-3308</contrib-id>
<address>
<email>gorazd.img@gmail.com</email>
</address>
<xref ref-type="aff" rid="mgg3658-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3658-cr-0002">
<name>
<surname>Lovrečić</surname>
<given-names>Luca</given-names>
</name>
<xref ref-type="aff" rid="mgg3658-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3658-cr-0003">
<name>
<surname>Tul</surname>
<given-names>Nataša</given-names>
</name>
<xref ref-type="aff" rid="mgg3658-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3658-cr-0004">
<name>
<surname>Teran</surname>
<given-names>Nataša</given-names>
</name>
<xref ref-type="aff" rid="mgg3658-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3658-cr-0005">
<name>
<surname>Peterlin</surname>
<given-names>Borut</given-names>
</name>
<xref ref-type="aff" rid="mgg3658-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="mgg3658-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Clinical Institute of Medical Genetics (CIMG)</named-content>
<institution>University Medical Centre Ljubljana</institution>
<named-content content-type="city">Ljubljana</named-content>
<country country="SI">Slovenia</country>
</aff>
<aff id="mgg3658-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Perinatology</named-content>
<named-content content-type="organisation-division">Division of Gynaecology and Obstetrics</named-content>
<institution>University Medical Centre Ljubljana</institution>
<named-content content-type="city">Ljubljana</named-content>
<country country="SI">Slovenia</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Gorazd Rudolf, Clinical Institute of Medical Genetics, University Medical Centre Ljubljana, Ljubljana, Slovenia.<break></break>
Email: <email>gorazd.img@gmail.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2019</year>
</pub-date>
<volume>7</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.2019.7.issue-6</issue-id>
<elocation-id>e658</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2019 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-7-e658.pdf" xlink:type="simple"></self-uri>
<abstract id="mgg3658-abs-0001">
<title>Abstract</title>
<sec id="mgg3658-sec-0001">
<title>Background</title>
<p>The implementation of molecular karyotyping has resulted in an improved diagnostic yield in the genetic diagnostics of congenital anomalies, detected prenatally or after the termination of pregnancy. However, the systematic epidemiologic ascertainment of copy number variations in the etiology of congenital anomalies has not yet been sufficiently explored.</p>
</sec>
<sec id="mgg3658-sec-0002">
<title>Methods</title>
<p>Consecutive fetuses, altogether 204, with major single or multiple congenital anomalies were ascertained by using the <styled-content style="fixed-case">SLOCAT</styled-content> registry for the period from 2011 to 2015. After excluding aneuploidies by using conventional karyotyping or Quantitative Fluorescence‐Polymerase Chain Reaction, array comparative genomic hybridization was performed for the detection of copy number variations.</p>
</sec>
<sec id="mgg3658-sec-0003">
<title>Results</title>
<p>We identified pathogenic or likely pathogenic copy number variations in 14 fetuses (6.8%); 2.9% in fetuses with isolated, and 3.9% in fetuses with multiple congenital anomalies. Additionally, aneuploidies and major structural chromosomal abnormalities were detected in 40.2%.</p>
</sec>
<sec id="mgg3658-sec-0004">
<title>Conclusion</title>
<p>Our systematic approach of ascertaining congenital anomalies resulted in explaining the etiology of congenital anomalies in 47% of fetuses after the termination of pregnancy. By using array comparative genomic hybridization, we found that copy number variations represent an important part in the etiology of multiple, as well as isolated congenital anomalies, which indicates the importance of analyzing copy number variations in the diagnostic approach of fetuses with congenital anomalies after the termination of pregnancy.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mgg3658-kwd-0001">congenital anomalies</kwd>
<kwd id="mgg3658-kwd-0002">copy number variations</kwd>
<kwd id="mgg3658-kwd-0003">epidemiology</kwd>
<kwd id="mgg3658-kwd-0004">molecular karyotyping</kwd>
<kwd id="mgg3658-kwd-0005">termination of pregnancy</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<page-count count="7"></page-count>
<word-count count="4747"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>mgg3658</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:10.07.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg3658-cit-1001" publication-type="journal">
<string-name>
<surname>Rudolf</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lovrečić</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tul</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Teran</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Peterlin</surname>
<given-names>B</given-names>
</string-name>. <article-title>The frequency of CNVs in a cohort population of consecutive fetuses with congenital anomalies after the termination of pregnancy</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2019</year>;<volume>7</volume>:<elocation-id>e658</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.658</pub-id>
<pub-id pub-id-type="pmid">31004418</pub-id></mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="mgg3658-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Congenital anomalies (CAs) occur in about 2%–3% of liveborn and 20% of stillborn infants (Valduga et al., <xref ref-type="ref" rid="mgg3658-bib-0024">2010</xref>). Thus, CAs are more prevalent that many chronic childhood diseases such as autism, pediatric cancers, and type 1 diabetes and are an important cause of neonatal mortality, childhood morbidity, and long‐term disability. They represent an important public health and epidemiological problem (Babkina &amp; Graham, <xref ref-type="ref" rid="mgg3658-bib-0001">2014</xref>; Di Gregorio et al., <xref ref-type="ref" rid="mgg3658-bib-0005">2015</xref>; Valduga et al., <xref ref-type="ref" rid="mgg3658-bib-0024">2010</xref>).</p>
<p>The etiology of CAs is complex; CAs can result from genetic factors, environmental factors, or a combination of both (D'Amours et al., <xref ref-type="ref" rid="mgg3658-bib-0004">2012</xref>; Szczałuba et al., <xref ref-type="ref" rid="mgg3658-bib-0022">2016</xref>). It is estimated that genetic factors represent an important cause of CAs and may be due to different genetic mechanisms: aneuploidies, deletions, and duplications of DNA segments (collectively known as copy number variations—CNVs), and single gene disorders (D'Amours et al., <xref ref-type="ref" rid="mgg3658-bib-0004">2012</xref>; Szczałuba et al., <xref ref-type="ref" rid="mgg3658-bib-0022">2016</xref>). Due to the genetic complexity, the targeted genetic diagnostics is usually problematic and challenging.</p>
<p>It has long been estimated that an important proportion of patients with CAs have submicroscopic chromosomal changes not detectable by conventional karyotyping (D'Amours et al., <xref ref-type="ref" rid="mgg3658-bib-0004">2012</xref>; Szczałuba et al., <xref ref-type="ref" rid="mgg3658-bib-0022">2016</xref>). In the last decade the availability of a comparative genomic hybridization using microarray technology (aCGH), enabled detection of CNVs down to few kb in size. The method has already replaced conventional karyotyping as a first‐tier test in the postnatal setting in patients with developmental delay, intellectual disability, autism spectrum disorders, and/or multiple congenital anomalies (Miller et al., <xref ref-type="ref" rid="mgg3658-bib-0011">2010</xref>; South, Lee, Lamb, Higgins, &amp; Kearney, <xref ref-type="ref" rid="mgg3658-bib-0018">2013</xref>). Large prospective and retrospective studies showed a 5%–10% increase in detection of clinically relevant CNVs in fetuses with prenatally detected ultrasound anomalies when compared to conventional karyotyping (Lovrecic et al., <xref ref-type="ref" rid="mgg3658-bib-0010">2016</xref>; Shaffer et al., <xref ref-type="ref" rid="mgg3658-bib-0017">2012</xref>; Srebniak et al., <xref ref-type="ref" rid="mgg3658-bib-0019">2016</xref>; Wapner et al., <xref ref-type="ref" rid="mgg3658-bib-0027">2012</xref>).</p>
<p>Finally, retrospective cohort studies investigating fetuses with CAs after the termination of pregnancy reported a 10%–24% diagnostic yield of aCGH (Di Gregorio et al., <xref ref-type="ref" rid="mgg3658-bib-0005">2015</xref>; Le Caignec et al., <xref ref-type="ref" rid="mgg3658-bib-0009">2005</xref>; Valduga et al., <xref ref-type="ref" rid="mgg3658-bib-0024">2010</xref>; Vialard et al., <xref ref-type="ref" rid="mgg3658-bib-0025">2009</xref>). Nevertheless, these studies were mainly done on selected and small samples, resulting from experiences of individual centers.</p>
<p>While the contribution of chromosomal abnormalities to the etiology of CAs in fetuses after the termination of pregnancy was already systematically addressed in the EUROCAT study (Dolk, Loane, &amp; Garne, <xref ref-type="ref" rid="mgg3658-bib-0006">2010</xref>), there is no systematic epidemiologic ascertainment of CNVs in the etiology of CAs.</p>
<p>Therefore, in this work, we systematically evaluated the detection rate of CNVs in a cohort of consecutive fetuses with single or multiple CAs after the termination of pregnancy ascertained in the SLOCAT registry for the period from 2011 to 2015.</p>
</sec>
<sec id="mgg3658-sec-0006">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="mgg3658-sec-0007">
<label>2.1</label>
<title>Ethical compliance</title>
<p>The study was approved by The Commission of the Republic of Slovenia for Medical Ethics.</p>
</sec>
<sec id="mgg3658-sec-0008">
<label>2.2</label>
<title>Patients and classification of CAs</title>
<p>Consecutive fetuses with major single or multiple CAs were ascertained by using the SLOCAT registry for the period from 2011 to 2015. The SLOCAT registry contains systematically collected clinical data of CAs, according to the EUROCAT methodology, classified by using the international classification of diseases and additionally, by the ontology of human phenotypes, information about pregnancies and exposures to external risk factors, as well as the results of the key genetic and non‐genetic testing.</p>
<p>The geographical area covered by the registry includes systematic data collection on CAs in the central Slovenian region, which covers about 40% of live births in Slovenia (6000 in year 2015). Additionally, SLOCAT covers virtually all complex cases of CAs in Slovenia, since UMC Ljubljana is a tertiary center and covers the diagnostics of complex CAs for the entire country of Slovenia.</p>
<p>According to the abovementioned methodology, the registry of CAs contains 204 fetuses with single or multiple CA for the aforementioned time period. CAs were detected during pregnancies which were subsequently terminated or were detected after a spontaneous abortion or intrauterine death. Each fetus was examined by a clinical geneticist and each underwent pathohistological examination. The gestational age of fetuses was from 13 to 40 weeks.</p>
</sec>
<sec id="mgg3658-sec-0009">
<label>2.3</label>
<title>The genetic analysis</title>
<p>All 204 fetuses were included in the genetic analysis. The genetic analysis of samples was carried out sequentially in order to detect genetic abnormalities. First, conventional karyotyping or rapid test for the detection of the most common aneuploidies Quantitative Fluorescence‐Polymerase Chain Reaction (QF‐PCR) was carried out on all samples for the detection of aneuploidies and major structural chromosomal abnormalities. On samples that returned normal results we performed comparative genomic hybridization (aCGH) to assess CNVs.</p>
</sec>
<sec id="mgg3658-sec-0010">
<label>2.4</label>
<title>DNA samples</title>
<p>DNA samples were collected by using the clinical biobank of CAs, which includes DNA samples isolated from the skin of the fetuses with CAs ascertained by using SLOCAT registry.</p>
<p>DNA was isolated according to manufacturer's protocol using Qiagen Mini kit (Qiagen, Valencia, CA). The quality and concentration parameters of DNA were measured with NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific Inc.) and Qubit 2.0 fluorometer (Life Technologies Inc.).</p>
</sec>
<sec id="mgg3658-sec-0011">
<label>2.5</label>
<title>Karyotyping and QF‐PCR</title>
<p>Karyotyping on GTG‐banded chromosomes (550 probes) was performed on fibroblasts. QF‐PCR for the detection of chromosomes 13, 18, 21, and sex chromosomes, was performed by using Genetic Analyser ABI 3500, Aneufast Multiplex QF‐PCR molGENTIX kit (Spain), following the manufacturer′s protocol.</p>
</sec>
<sec id="mgg3658-sec-0012">
<label>2.6</label>
<title>Molecular karyotyping</title>
<p>Molecular karyotyping was performed by using oligonucleotide microarray with approximately 55,000 probes distributed throughout the genome (Agilent, Human CGH microarray Kit 8 × 60k, hg19 UCSC, NCBI Build 37, February 2009), which provides an average resolution of approximately 100 kb. The sample was compared with a commercial reference sample of DNA (Agilent). The results were analyzed by software CytoGenomics 3.0 (Agilent).</p>
</sec>
<sec id="mgg3658-sec-0013">
<label>2.7</label>
<title>Classification of aCGH results</title>
<p>Called CNVs were aligned with known aberrations in publicly available databases ClinGen (<ext-link ext-link-type="uri" xlink:href="http://dbsearch.clinicalgenome.org/search/">http://dbsearch.clinicalgenome.org/search/</ext-link>), DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>), ClinVar (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/">http://www.ncbi.nlm.nih.gov/clinvar/</ext-link>), Database of Genomic Variants—DGV (<ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv/app/home">http://dgv.tcag.ca/dgv/app/home</ext-link>), as well as with in‐house database of detected variants and their clinical significance ascertained by trained analysts. CNVs were classified into three groups, benign, VOUS, and pathogenic, all according to ACMG Standards and Guidelines (12). Benign CNVs were those reported in abovementioned databases as benign or present in our in‐house database in more than 1% of cases. Pathogenic CNVs were either known microdeletion/microduplication syndromes or large genome copy number gain and losses, described as pathogenic in the scientific literature (PubMed). Variants classified as VOUS were either already present in cited databases as VOUS or bigger than 200 kb with OMIM gene content.</p>
</sec>
</sec>
<sec id="mgg3658-sec-0014">
<label>3</label>
<title>RESULTS</title>
<p>For the observed period from 2011 to 2015, a sample of 204 consecutive fetuses with isolated or multiple major CAs were recorded in the SLOCAT registry, according to the EUROCAT methodology.</p>
<p>As much as 42.7% (87) cases were with isolated CA and 57.3% (117) with multiple CAs.</p>
<p>Isolated CAs were further analyzed, depending on the type of abnormality (Figure <xref ref-type="fig" rid="mgg3658-fig-0001">1</xref>).</p>
<fig fig-type="Figure" id="mgg3658-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Representation of single <styled-content style="fixed-case">CA</styled-content>s, according to the <styled-content style="fixed-case">ICD</styled-content>10 nomenclature, in the study sample. <styled-content style="fixed-case">CA</styled-content>s—congenital anomalies</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-7-e658-g001"></graphic>
</fig>
<p>Aneuploidies and major structural chromosomal abnormalities using conventional karyotyping or QF‐PCR were detected in 40.2% of fetuses; in isolated CAs in 37.9% and in multiple CAs in 41.9%. The most common was trisomy 18 (26.9%), followed by monosomy × (24.3%), trisomy 21 (23.1%), triploidy (16.7%), and trisomy 13 (6.4%). There was a case of mosaic trisomy 22 and a case of derivative chromosome 9 (46,XY,der(9)t(8;9)(p23;p22).ish der(9)(wcp8 + ,D8S504 + ,D9Z1 + )).</p>
<p>In the group of isolated CAs major chromosomal anomalies were most frequent in the cases with hydrops (85%), followed by the CAs of eye, ear, face, and neck (80%), CAs and deformations of the musculoskeletal system (40%), CAs of the urinary system (16.7%), CAs of the circulatory system (15.4%), and CAs of the nervous system (12.5%).</p>
<p>In fetuses with normal karyotype pathogenic or likely pathogenic CNVs were detected in 14 cases representing 6.8% of all; 2.9% represented fetuses with isolated, and 3.9% represented fetuses with multiple CAs.</p>
<p>Considering the group of fetuses with isolated CAs alone, pathogenic or likely pathogenic CNVs were detected in 6.9% (Table <xref ref-type="table" rid="mgg3658-tbl-0001">1</xref>).</p>
<table-wrap id="mgg3658-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Results of aCGH in a group of isolated CAs</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Fetus</th>
<th align="left" colspan="1" rowspan="1" valign="top">CA</th>
<th align="left" colspan="1" rowspan="1" valign="top">aCGH result</th>
<th align="left" colspan="1" rowspan="1" valign="top">Categorization</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">Agenesis of corpus callosum</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 2q33.3q35(208,814,372–219,814,526) × 3</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">Occipital meningocele</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 18p11.32p11.21(148,963‐14,081,887) × 4</td>
<td align="left" colspan="1" rowspan="1">Pathogenic: 18p tetrasomy (MIM#614290)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">Cystic hygroma</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 2p16.3(51,109,690–51,251,557) × 1</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">Pulmonary valve atresia</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 10q23.1q23.2(82,117,139–88,710,206) × 3</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">Short femur</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 6q15(91,132,714–91,651,975) × 3</td>
<td align="left" colspan="1" rowspan="1">VOUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">Hemivertebrae</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 16p11.2(29,673,954–30,190,568) × 1</td>
<td align="left" colspan="1" rowspan="1">Pathogenic; a known 16p11.2 deletion syndrome, with reduced penetrance (MIM#611913)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">Bilateral radial aplasia</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 1q21.1(145,415,190–145,799,602) × 1</td>
<td align="left" colspan="1" rowspan="1">Pathogenic; Thrombocytopenia‐absent radius (TAR) syndrome (MIM#274000)</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Fetus 1 carried an 11 Mb large duplication of chromosome 2q33.3q35. Interstitial duplications of the long arm of chromosome 2 were previously associated with intellectual disability, developmental delay, hypotonia, dysmorphic features, and different CAs; additionally, partial duplications of the long arm of chromosome 2 were described in cases with CAs of the central nervous system (Sebold et al., <xref ref-type="ref" rid="mgg3658-bib-0016">2005</xref>; Usui et al., <xref ref-type="ref" rid="mgg3658-bib-0023">2013</xref>).</p>
<p>A 142 kb large deletion spanning exons 3–5 of the NRXN1 gene was found in fetus 3. Intragenic deletions in this gene are described as a risk factor for autism and schizophrenia and are also found in individuals with developmental delay, intellectual disability, and dysmorphic features. Two prenatal cases with cystic hygroma were previously reported (Béna et al., <xref ref-type="ref" rid="mgg3658-bib-0002">2013</xref>; Dabell et al., <xref ref-type="ref" rid="mgg3658-bib-0003">2013</xref>; Viñas‐Jornet et al., <xref ref-type="ref" rid="mgg3658-bib-0026">2014</xref>).</p>
<p>In fetus 4, a 6 Mb large duplication of chromosome 10q23.1q23.2 was found. Similar duplications in this region have been described in individuals with dysmorphic feature, delay in speech and development with incomplete penetrance; furthermore, CAs of the heart and the heart valves were also described (Wong et al., <xref ref-type="ref" rid="mgg3658-bib-0028">2015</xref>).</p>
<p>In the group of fetuses with multiple CAs alone, pathogenic or likely pathogenic CNVs were detected in 6.8% (Table <xref ref-type="table" rid="mgg3658-tbl-0002">2</xref>).</p>
<table-wrap id="mgg3658-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Results of aCGH in a group of multiple CAs</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Fetus</th>
<th align="left" colspan="1" rowspan="1" valign="top">CA</th>
<th align="left" colspan="1" rowspan="1" valign="top">aCGH result</th>
<th align="left" colspan="1" rowspan="1" valign="top">Categorization</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">Spina bifida, ventriculomegaly, cerebellum hypoplasia</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 3p26.3(93,949–294,559) × 1, 3q26.1q29(166,876,046–197,837,049) × 3</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">Omphalocele, unilateral cleft lip and palate</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 1q21.1q21.2(146,507,518–147,379,946) × 1,4q35.2(189,247,673–190,552,305) × 1</td>
<td align="left" colspan="1" rowspan="1">Pathogenic; a known 1q21 deletion syndrome, with reduced penetrance (MIM#612474)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">Reduction anomalies of upper limbs, cleft palate</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 5p13.2(36,952,801‐37,024,752) × 1</td>
<td align="left" colspan="1" rowspan="1">Pathogenic: Cornelia de Lange syndrome (MIM#122470)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">Micrognathia, nuchal edema, agenesis of thymus, ambivalent genitalia, anal atresia</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 22q11.1q11.21(17,397,498–18,628,078) × 3‐4</td>
<td align="left" colspan="1" rowspan="1">Pathogenic; a known 22q11.2 duplication syndrome (MIM#608363)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">Cystic hygroma, hydrops</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 15q13.2q13.3(30,653,877–32,861,626) × 3</td>
<td align="left" colspan="1" rowspan="1">VOUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">Cystic hygroma, hypoplastic left heart</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 20p13(60,747‐748,964) × 1,20q13.13q13.33(47,912,240–62,880,583) × 3</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">Cystic hygroma, hydrops, omphalocele, alveolar capillary dysplasia</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 16q24.1(86,211,031–86,649,743) × 1</td>
<td align="left" colspan="1" rowspan="1">Pathogenic; congenital alveolar capillary dysplasia (MIM#265380)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">Ascites, bilateral hydrothorax, malformation of great arteries</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] Xq13.3(74,463,757–74,651,249) × 3</td>
<td align="left" colspan="1" rowspan="1">VOUS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">16</td>
<td align="left" colspan="1" rowspan="1">Micrognathia, ASD, VSD, short femurs, equinovarus</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 6p25.3p25.1(206,749–5,507,458) × 3 P</td>
<td align="left" colspan="1" rowspan="1">Likely pathogenic</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">Dilated cardiomyopathy, hydrops</td>
<td align="left" colspan="1" rowspan="1">arr[hg19] 16p13.11(14,910,205–16,525,348) × 3</td>
<td align="left" colspan="1" rowspan="1">Pathogenic; a known 16p13.11 duplicaton syndrome with reduced penetrance (ORPHA:261243)</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In fetus 8 a duplication of chromosome 3q26.1q29 was found. Terminal duplications of chromosome 3q26.1q29 were associated with developmental delay, intellectual disability, CAs of the heart, cleft palate, dysmorphic features, and also CAs of CNS (Ounap, Ilus, &amp; Bartsch, <xref ref-type="ref" rid="mgg3658-bib-0014">2005</xref>; Rodríguez et al., <xref ref-type="ref" rid="mgg3658-bib-0015">2014</xref>).</p>
<p>Additionally, a deletion of chromosome 3p26.3 was present, which, according to the literature and the size, is most likely a VOUS.</p>
<p>Two deletions were found in fetus 9; a deletion of chromosome 1q21.1q21.2 and a deletion of chromosome 4q35.2. First deletion represents a known 1q21 deletion syndrome with developmental delay, dysmorphic features, microcephaly, hernias, heart, skeletal, and genitourinary anomalies. According to the literature the 4q35.2 deletion is most likely a VOUS.</p>
<p>In fetus 13 a deletion of chromosome 20p13 and a duplication of chromosome 20q13.13q13.33 were found. Terminal deletions of the short arm of chromosome 20 were associated with developmental delay, intellectual disability, and dysmorphic features (Jezela‐Stanek, Kucharczyk, Pelc, Gutkowska, &amp; Krajewska‐Walasek, <xref ref-type="ref" rid="mgg3658-bib-0008">2013</xref>). Large terminal duplications of the long arm of chromosome 20 were previously reported in individuals with developmental delay, dysmorphic features, cleft lip and palate, CAs of the heart and thorax (Starr, Truemper, Pickering, Sanger, &amp; Olney, <xref ref-type="ref" rid="mgg3658-bib-0021">2014</xref>).</p>
<p>Fetus 16 carried a microduplication of chromosome 6p25.3p25. Terminal duplication of a short arm of chromosome 6 were already reported in cases with intrauterine growth retardation, choanal atresia, anomalies of the heart and heart valves, microcephaly, dysmorphic features, anomalies of the hands and feet, developmental delay, and intellectual disability (Nakane et al., <xref ref-type="ref" rid="mgg3658-bib-0012">2013</xref>).</p>
<p>Among all 14 detected CNVs 7 were classified as pathogenic and 7 as likely pathogenic. In additional 3 cases (1.5%) the CNVs were classified as VOUS. The duplication in the region 6q15 includes only gene <italic>MAP3K7</italic> (OMIM*602614), linked to two autosomal, dominantly inherited human disorders, where missense mutations and in‐frame deletions were reported as causative. The reports of similar duplication are lacking in all available databases, therefore it represents a VOUS. Most likely, it is not related to a short femur, since it was inherited from an apparently healthy mother.</p>
<p>A 15q13.2q13.3 duplication involves eight OMIM genes, which have not been reported as causative for human disease when represented in three copies, except for <italic>CHRNA7</italic> (OMIM*118511). Deletion of this region represents a known risk factor for variable phenotype, including developmental delay, intellectual disability, autism, seizures, and ADHD. On the other hand, the clinical causality of duplication is still questionable, as it is inherited from a healthy parent in more than 50% of reported cases. Its penetrance is most likely influenced by other factors (Gillentine &amp; Schaaf, <xref ref-type="ref" rid="mgg3658-bib-0007">2015</xref>).</p>
<p>The third VOUS is a Xq13.3 duplication in a fetus with congenital heart anomaly, where part of <italic>ZDHHC15</italic> gene (OMIM*300576) is duplicated. This gene is a candidate gene for X‐linked mental retardation‐91, but only one family has been reported with no congenital heart anomalies. Further cases are needed to clarify the genotype‐phenotype correlation.</p>
<p>A cumulative additional diagnostic yield of aCGH in our study was 11.4%, when compared to conventional karyotyping.</p>
</sec>
<sec id="mgg3658-sec-0015">
<label>4</label>
<title>DISCUSSION</title>
<p>The purpose of our study was to evaluate the contribution of CNV in the epidemiology of CAs on a systematically collected sample of consecutive fetuses with major unselected isolated or multiple CAs after the termination of pregnancy for the period from 2011 to 2015. The frequency of pathogenic or likely pathogenic CNVs in our sample was 6.8%.</p>
<p>Previous studies performed on fetuses with CAs after the termination of pregnancy and normal karyotypes, which were mainly focused on small (not exceeding 50 fetuses) and selected samples of fetuses with mainly multiple CAs, gave a detection rate of aCGH between 10% and 24%, showing relatively high variability (Di Gregorio et al., <xref ref-type="ref" rid="mgg3658-bib-0005">2015</xref>; Le Caignec et al., <xref ref-type="ref" rid="mgg3658-bib-0009">2005</xref>; Valduga et al., <xref ref-type="ref" rid="mgg3658-bib-0024">2010</xref>; Vialard et al., <xref ref-type="ref" rid="mgg3658-bib-0025">2009</xref>). The lowest detection rate (10%) was in a study from Valduga (2010) that included 50 fetuses with multiple CAs and the highest (24%) was found in a study from Di Gregorio et al. (<xref ref-type="ref" rid="mgg3658-bib-0005">2015</xref>) after analyzing 33 fetuses with isolated and multiple CAs. The discrepancies between these studies may be due to the size of the samples, different inclusion criteria, different microarray platforms, and the inclusion of VOUS among the identified CNVs (Di Gregorio et al., <xref ref-type="ref" rid="mgg3658-bib-0005">2015</xref>). The diagnostic yield (11.4%) of aCGH in our study is among the lowest of the mentioned studies, which can be explained by the highest percent of isolated CAs in the sample and the fact that the sample was represented by consecutive fetuses with CAs, which were not selected by the number or the type of CAs.</p>
<p>Interestingly, in contrast to our expectations, the contribution of CNVs was very similar in the group of isolated and multiple CAs, which implicates the importance of applying aCGH in the diagnostic protocol also in the cases with isolated CAs.</p>
<p>Unlike the studies performed on fetuses after the termination of pregnancy, large prospective and retrospective studies on fetuses with prenatally detected ultrasound anomalies showed a lower, 5%–10% increase in aCGH in detection of clinically relevant copy number variation when compared to conventional karyotyping (Lovrecic et al., <xref ref-type="ref" rid="mgg3658-bib-0010">2016</xref>; Shaffer et al., <xref ref-type="ref" rid="mgg3658-bib-0017">2012</xref>; Srebniak et al., <xref ref-type="ref" rid="mgg3658-bib-0019">2016</xref>; Wapner et al., <xref ref-type="ref" rid="mgg3658-bib-0027">2012</xref>).</p>
<p>There is a well‐known evidence that the diagnostic yield of classical karyotype in fetuses presenting with isolated or multiple CAs is more than 18%. In retrospective series, chromosomal abnormalities were found in 2%–18% of cases when isolated and in 18%–35% when multiple CAs were prenatally detected on ultrasound (Nicholaides, Snijders, Gosden, Berry, &amp; Campbell, <xref ref-type="ref" rid="mgg3658-bib-0013">1992</xref>; Staebler et al., <xref ref-type="ref" rid="mgg3658-bib-0020">2005</xref>). In our study, in addition to CNV contribution, we also analyzed the contribution of aneuploidies and major structural chromosomal anomalies in the etiology of CAs; we found them in 40.2% of cases. This result can be compared to 48% established in the EUROCAT study (Dolk et al., <xref ref-type="ref" rid="mgg3658-bib-0006">2010</xref>), as the EUROCAT methodology for the assessment and classification of CAs was the same in both studies.</p>
<p>The strength of our study is a systematic approach on a non‐selected sample of consecutive fetuses which were thoroughly ascertained by clinical genetic and pathohistological examination through a registry of CAs rather than performing the analysis on selected cases of CAs with a high probability of chromosomal abnormality. Also, the precise characterization of the phenotype, which is an important part of the diagnostic process, can be much more detailed after the termination of pregnancy, as in our approach, compared to the period during the pregnancy.</p>
<p>The limitations of our study are, a still relatively small sample size due to small Slovenian population, despite a 5‐year study period, and, in terms of addressing a comprehensive genetic epidemiology of CAs, not addressing possible single gene disorders.</p>
<p>The systematic approach for the detection of the etiology of CAs including conventional and molecular karyotyping as employed in our study resulted in explaining the etiology in 47% of cases, which represents a significant diagnostic yield. This has important consequences for the patients, as it enables the identification of the cause of CAs and, consequently, their prevention, as well as for the understanding the genetic epidemiology of CAs and designing optimal professional and cost‐effective diagnostic algorithms for the diagnostics of CAs. Altogether, coupled with the use of standardized registries of CAs, this enables a more efficient public health approach in the process of diagnostics and prevention of CAs.</p>
<p>In summary, in our study, which was ascertained on a cohort population of consecutive fetuses with unselected isolated and multiple CAs after the termination of pregnancy, the frequency of CNVs was 6.8%, which implicates an important role of aCGH in the genetic diagnostics of fetuses with CAs after the termination of pregnancy.</p>
</sec>
<sec id="mgg3658-sec-0016" sec-type="COI-statement">
<title>CONFLICT OF INTEREST STATEMENT</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not‐for‐profit sectors. The authors stated that there are no conflicts of interest regarding the publication of this manuscript. The authors also state that they have had full control of all primary data and that they agree to allow the Journal to review their data if requested.</p>
</sec>
</body>
<back>
<ref-list content-type="cited-references" id="mgg3658-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg3658-bib-0001">
<mixed-citation id="mgg3658-cit-0001" publication-type="journal">
<string-name>
<surname>Babkina</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Graham</surname>, <given-names>J. M.</given-names>
<suffix>Jr</suffix>
</string-name> (<year>2014</year>). <article-title>New genetic testing in prenatal diagnosis</article-title>. <source xml:lang="en"/>Seminars in Fetal &amp; Neonatal Medicine, <volume>19</volume>, <fpage>214</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.siny.2013.10.005</pub-id>
<pub-id pub-id-type="pmid">24315623</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0002">
<mixed-citation id="mgg3658-cit-0002" publication-type="journal">
<string-name>
<surname>Béna</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>van Ravenswaaij‐Arts</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Stark</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Dijkhuizen</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>Schoumans</surname>, <given-names>J.</given-names>
</string-name> (<year>2013</year>). <article-title>Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics., <volume>162B</volume>, <fpage>388</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32148</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3658-bib-0003">
<mixed-citation id="mgg3658-cit-0003" publication-type="journal">
<string-name>
<surname>Dabell</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Rosenfeld</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Bader</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Escobar</surname>, <given-names>L. F.</given-names>
</string-name>, <string-name>
<surname>El‐Khechen</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Vallee</surname>, <given-names>S. E.</given-names>
</string-name>, … <string-name>
<surname>Shaffer</surname>, <given-names>L. G.</given-names>
</string-name> (<year>2013</year>). <article-title>Investigation of NRXN1 deletions: clinical and molecular characterization</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>161A</volume>, <fpage>717</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35780</pub-id>
<pub-id pub-id-type="pmid">23495017</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0004">
<mixed-citation id="mgg3658-cit-0004" publication-type="journal">
<string-name>
<surname>D'Amours</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Kibar</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Mathonnet</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Fetni</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Tihy</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Désilets</surname>, <given-names>V.</given-names>
</string-name>, … <string-name>
<surname>Lemyre</surname>, <given-names>E.</given-names>
</string-name> (<year>2012</year>). <article-title>Whole‐genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>81</volume>, <fpage>128</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01687.x</pub-id>
<pub-id pub-id-type="pmid">21496010</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0005">
<mixed-citation id="mgg3658-cit-0005" publication-type="journal">
<string-name>
<surname>Di Gregorio</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Gai</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Botta</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Calcia</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Pappi</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Talarico</surname>, <given-names>F.</given-names>
</string-name>, … <string-name>
<surname>Brussino</surname>, <given-names>A.</given-names>
</string-name> (<year>2015</year>). <article-title>Array‐comparative genomic hybridization analysis in fetuses with major congenital malformations reveals that 24% of cases have pathogenic deletions/duplications</article-title>. <source xml:lang="en"/>Cytogenet Genome Research, <volume>147</volume>, <fpage>10</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1159/000442308</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3658-bib-0006">
<mixed-citation id="mgg3658-cit-0006" publication-type="journal">
<string-name>
<surname>Dolk</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Loane</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Garne</surname>, <given-names>E.</given-names>
</string-name> (<year>2010</year>). <article-title>The prevalence of congenital anomalies in Europe</article-title>. <source xml:lang="en"/>Advances in Experimental Medicine and Biology, <volume>686</volume>, <fpage>349</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1007/978-90-481-9485-8_20</pub-id>
<pub-id pub-id-type="pmid">20824455</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0007">
<mixed-citation id="mgg3658-cit-0007" publication-type="journal">
<string-name>
<surname>Gillentine</surname>, <given-names>M. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Schaaf</surname>, <given-names>C. P.</given-names>
</string-name> (<year>2015</year>). <article-title>The human clinical phenotypes of altered CHRNA7 copy number</article-title>. <source xml:lang="en"/>Biochemical Pharmacology, <volume>97</volume>, <fpage>352</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2015.06.012</pub-id>
<pub-id pub-id-type="pmid">26095975</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0008">
<mixed-citation id="mgg3658-cit-0008" publication-type="journal">
<string-name>
<surname>Jezela‐Stanek</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Kucharczyk</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pelc</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Gutkowska</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Krajewska‐Walasek</surname>, <given-names>M.</given-names>
</string-name> (<year>2013</year>). <article-title>1.15 Mb microdeletion in chromosome band 20p13 associated with moderate developmental delay‐additional case and data's review</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>161A</volume>, <fpage>172</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35654</pub-id>
<pub-id pub-id-type="pmid">23165892</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0009">
<mixed-citation id="mgg3658-cit-0009" publication-type="journal">
<string-name>
<surname>Le Caignec</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Boceno</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Saugier‐Veber</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Jacquemont</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Joubert</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>David</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>, …</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2005</year>). <article-title>Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations</article-title>. <source xml:lang="en"/>Journal of Medical Genetics
<volume>42</volume>, <fpage>121</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2004.025478</pub-id>
<pub-id pub-id-type="pmid">15689449</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0010">
<mixed-citation id="mgg3658-cit-0010" publication-type="journal">
<string-name>
<surname>Lovrecic</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Remec</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Volk</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rudolf</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Writzl</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>Peterlin</surname>, <given-names>B.</given-names>
</string-name> (<year>2016</year>). <article-title>Clinical utility of array comparative genomic hybridisation in prenatal setting</article-title>. <source xml:lang="en"/>BMC Medical Genetics, <volume>17</volume>, <fpage>81</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-016-0345-8</pub-id>
<pub-id pub-id-type="pmid">27846804</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0011">
<mixed-citation id="mgg3658-cit-0011" publication-type="journal">
<string-name>
<surname>Miller</surname>, <given-names>D. T.</given-names>
</string-name>, <string-name>
<surname>Adam</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Aradhya</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Biesecker</surname>, <given-names>L. G.</given-names>
</string-name>, <string-name>
<surname>Brothman</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Carter</surname>, <given-names>N. P.</given-names>
</string-name>, … <string-name>
<surname>Ledbetter</surname>, <given-names>D. H.</given-names>
</string-name> (<year>2010</year>). <article-title>Consensus statement: chromosomal microarray is a first‐tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>86</volume>, <fpage>749</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id>
<pub-id pub-id-type="pmid">20466091</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0012">
<mixed-citation id="mgg3658-cit-0012" publication-type="journal">
<string-name>
<surname>Nakane</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Kousuke</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Sonoko</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Yuko</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Sato</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kubota</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Sugita</surname>, <given-names>K.</given-names>
</string-name> (<year>2013</year>). <article-title>6p subtelomere deletion with congenital glaucoma, severe mental retardation, and growth impairment</article-title>. <source xml:lang="en"/>Pediatrics International, <volume>55</volume>, <fpage>376</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-200X.2012.03729.x</pub-id>
<pub-id pub-id-type="pmid">23782370</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0013">
<mixed-citation id="mgg3658-cit-0013" publication-type="journal">
<string-name>
<surname>Nicolaides</surname>, <given-names>K. H.</given-names>
</string-name>, <string-name>
<surname>Snijders</surname>, <given-names>R. J.</given-names>
</string-name>, <string-name>
<surname>Gosden</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Berry</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Campbell</surname>, <given-names>S.</given-names>
</string-name> (<year>1992</year>). <article-title>Ultrasonographically detectable markers of fetal chromosomal abnormalities</article-title>. <source xml:lang="en"/>Lancet, <volume>340</volume>, <fpage>704</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">1355807</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0014">
<mixed-citation id="mgg3658-cit-0014" publication-type="journal">
<string-name>
<surname>Ounap</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Ilus</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Bartsch</surname>, <given-names>O.</given-names>
</string-name> (<year>2005</year>). <article-title>A girl with inverted triplication of chromosome 3q25.3 –&gt; q29 and multiple congenital anomalies consistent with 3q duplication syndrome</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>134</volume>, <fpage>434</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30134</pub-id>
<pub-id pub-id-type="pmid">15793836</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0015">
<mixed-citation id="mgg3658-cit-0015" publication-type="journal">
<string-name>
<surname>Rodríguez</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Bhatt</surname>, <given-names>S. S.</given-names>
</string-name>, <string-name>
<surname>García‐Castro</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Plasencia</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Fernández‐Toral</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Abarca</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Liehr</surname>, <given-names>T.</given-names>
</string-name> (<year>2014</year>). <article-title>A unique case of a discontinuous duplication 3q26.1‐3q28 resulting from a segregation error of a maternal complex chromosomal rearrangement involving an insertion and an inversion</article-title>. <source xml:lang="en"/>Gene, <volume>535</volume>, <fpage>165</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.11.041</pub-id>
<pub-id pub-id-type="pmid">24316129</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0016">
<mixed-citation id="mgg3658-cit-0016" publication-type="journal">
<string-name>
<surname>Sebold</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<surname>Romie</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Szymanska</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Torres‐Martinez</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Thurston</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Muesing</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Vance</surname>, <given-names>G. H.</given-names>
</string-name> (<year>2005</year>). <article-title>Partial trisomy 2q: report of a patient with dup (2)(q33.1q35)</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>134A</volume>, <fpage>80</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30463</pub-id>
<pub-id pub-id-type="pmid">15690398</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0017">
<mixed-citation id="mgg3658-cit-0017" publication-type="journal">
<string-name>
<surname>Shaffer</surname>, <given-names>L. G.</given-names>
</string-name>, <string-name>
<surname>Dabell</surname>, <given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Fisher</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Coppinger</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Bandholz</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Ellison</surname>, <given-names>J. W.</given-names>
</string-name>, … <string-name>
<surname>Rosenfeld</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2012</year>). <article-title>Experience with microarray‐based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies</article-title>. <source xml:lang="en"/>Prenatal Diagnosis, <volume>32</volume>, <fpage>976</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1002/pd.3945</pub-id>
<pub-id pub-id-type="pmid">22865506</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0018">
<mixed-citation id="mgg3658-cit-0018" publication-type="journal">
<string-name>
<surname>South</surname>, <given-names>S.T.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Lamb</surname>, <given-names>A. N.</given-names>
</string-name>, <string-name>
<surname>Higgins</surname>, <given-names>A. W.</given-names>
</string-name>, &amp; <string-name>
<surname>Kearney</surname>, <given-names>H. M.</given-names>
</string-name>; <collab collab-type="authors">Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee</collab>
. (<year>2013</year>). <article-title>ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013</article-title>. <source xml:lang="en"/>Genetics in Medicine
<volume>15</volume>, <fpage>901</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2013.129</pub-id>
<pub-id pub-id-type="pmid">24071793</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0019">
<mixed-citation id="mgg3658-cit-0019" publication-type="journal">
<string-name>
<surname>Srebniak</surname>, <given-names>M. I.</given-names>
</string-name>, <string-name>
<surname>Didreich</surname>, <given-names>K. E.</given-names>
</string-name>, <string-name>
<surname>Joosten</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Govaerts</surname>, <given-names>L. C.</given-names>
</string-name>, <string-name>
<surname>Knijnenburg</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>, <given-names>F. A.</given-names>
</string-name>, … <string-name>
<surname>Van Opstal</surname>, <given-names>D.</given-names>
</string-name> (<year>2016</year>). <article-title>Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs</article-title>. <source xml:lang="en"/>European Journal of Human Genetics, <volume>24</volume>, <fpage>645</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2015.193</pub-id>
<pub-id pub-id-type="pmid">26328504</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0020">
<mixed-citation id="mgg3658-cit-0020" publication-type="journal">
<string-name>
<surname>Staebler</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Donner</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Van Regemorter</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Duprez</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>De Maertelaer</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Devreker</surname>, <given-names>F.</given-names>
</string-name>, &amp; <string-name>
<surname>Avni</surname>, <given-names>F.</given-names>
</string-name> (<year>2005</year>). <article-title>Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound?</article-title>
<source xml:lang="en"/>Prenatal Diagnosis, <volume>25</volume>, <fpage>567</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1002/pd.1187</pub-id>
<pub-id pub-id-type="pmid">16032766</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0021">
<mixed-citation id="mgg3658-cit-0021" publication-type="journal">
<string-name>
<surname>Starr</surname>, <given-names>L. J.</given-names>
</string-name>, <string-name>
<surname>Truemper</surname>, <given-names>E. J.</given-names>
</string-name>, <string-name>
<surname>Pickering</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<surname>Sanger</surname>, <given-names>W. G.</given-names>
</string-name>, &amp; <string-name>
<surname>Olney</surname>, <given-names>A. H.</given-names>
</string-name> (<year>2014</year>). <article-title>Duplication of 20qter and deletion of 20pter due to paternal pericentric inversion: patient report and review of 20qter duplications</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>164A</volume>, <fpage>2020</fpage>–<lpage>2024</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.34020</pub-id>
<pub-id pub-id-type="pmid">24954807</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0022">
<mixed-citation id="mgg3658-cit-0022" publication-type="journal">
<string-name>
<surname>Szczałuba</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Nowakowska</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Sobecka</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Smyk</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Castaneda</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Klapecki</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Demkow</surname>, <given-names>U.</given-names>
</string-name> (<year>2016</year>). <article-title>Application of Array Comparative Genomic Hybridization in Newborns with Multiple Congenital Anomalies</article-title>. <source xml:lang="en"/>Advances in Experimental Medicine and Biology, <volume>912</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/5584_2016_235</pub-id>
<pub-id pub-id-type="pmid">26987320</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0023">
<mixed-citation id="mgg3658-cit-0023" publication-type="journal">
<string-name>
<surname>Usui</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Shimojima</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Sugawara</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kawasaki</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Shigematu</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Yamamoto</surname>, <given-names>T.</given-names>
</string-name> (<year>2013</year>). <article-title>Interstitial duplication of 2q32.1‐q33.3 in a patient with epilepsy, developmental delay, and autistic behavior</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>161A</volume>, <fpage>1078</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35679</pub-id>
<pub-id pub-id-type="pmid">23463730</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0024">
<mixed-citation id="mgg3658-cit-0024" publication-type="journal">
<string-name>
<surname>Valduga</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Philippe</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Bach Segura</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Thiebaugeorges</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Miton</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Beri</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Jonveaux</surname>, <given-names>P.</given-names>
</string-name> (<year>2010</year>). <article-title>A retrospective study by oligonucleotide array‐CGH analysis in 50 fetuses with multiple malformations</article-title>. <source xml:lang="en"/>Prenatal Diagnosis, <volume>30</volume>, <fpage>333</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1002/pd.2460</pub-id>
<pub-id pub-id-type="pmid">20155755</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0025">
<mixed-citation id="mgg3658-cit-0025" publication-type="journal">
<string-name>
<surname>Vialard</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Molina Gomes</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Leroy</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Quarello</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Escalona</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Le Sciellour</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Selva</surname>, <given-names>J.</given-names>
</string-name> (<year>2009</year>). <article-title>Array comparative genomic hybridization in prenatal diagnosis: another experience</article-title>. <source xml:lang="en"/>Fetal Diagnosis and Therapy, <volume>25</volume>, <fpage>277</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1159/000224112</pub-id>
<pub-id pub-id-type="pmid">19521095</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0026">
<mixed-citation id="mgg3658-cit-0026" publication-type="journal">
<string-name>
<surname>Viñas‐Jornet</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Esteba‐Castillo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Gabau</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ribas‐Vidal</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Baena</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>San</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Guitart</surname>, <given-names>M.</given-names>
</string-name> (<year>2014</year>). <article-title>A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion</article-title>. <source xml:lang="en"/>Molecular Genetics and Genomic Medicine, <volume>2</volume>, <fpage>512</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1002/mgg3.105</pub-id>
<pub-id pub-id-type="pmid">25614873</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0027">
<mixed-citation id="mgg3658-cit-0027" publication-type="journal">
<string-name>
<surname>Wapner</surname>, <given-names>R. J.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>C. L.</given-names>
</string-name>, <string-name>
<surname>Levy</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Ballif</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Eng</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Zachary</surname>, <given-names>J. M.</given-names>
</string-name>, … <string-name>
<surname>Jackson</surname>, <given-names>L.</given-names>
</string-name> (<year>2012</year>). <article-title>Chromosomal microarray versus karyotyping for prenatal diagnosis</article-title>. <source xml:lang="en"/>New England Journal of Medicine, <volume>367</volume>, <fpage>2175</fpage>–<lpage>2178</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1203382</pub-id>
<pub-id pub-id-type="pmid">23215555</pub-id></mixed-citation>
</ref>
<ref id="mgg3658-bib-0028">
<mixed-citation id="mgg3658-cit-0028" publication-type="journal">
<string-name>
<surname>Wong</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Chou</surname>, <given-names>H. H.</given-names>
</string-name>, <string-name>
<surname>Chao</surname>, <given-names>C. N.</given-names>
</string-name>, <string-name>
<surname>Leung</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>Y. H.</given-names>
</string-name>, &amp; <string-name>
<surname>Hsu</surname>, <given-names>C. D.</given-names>
</string-name> (<year>2015</year>). <article-title>Distal 10q trisomy with copy number gain in chromosome region 10q23.1‐10q25.1: the Wnt signaling pathway is the most pertinent to the gene content in the region of copy number gain: a case report</article-title>. <source xml:lang="en"/>BMC Research Notes
<volume>8</volume>, <fpage>250</fpage>
<pub-id pub-id-type="doi">10.1186/s13104-015-1213-x</pub-id>
<pub-id pub-id-type="pmid">26088875</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>